Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Moksha8

Moksha8?uq=UG6efJS6
2007 FOUNDED
PRIVATE STATUS
201-300 EMPLOYEES
Later Stage VC LATEST DEAL TYPE (Cancelled)
$125M LATEST DEAL AMOUNT
5 INVESTORS
Description

Developer of therapeutics designed to provide treatment for mental health disorders. The company's therapeutics focuses on commercializing the medicines in class operations and strong FCPA compliance, enabling patients to start begin treatment more quickly and result in a higher likelihood of a successful treatment.

Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Other Industries
Pharmaceuticals
Primary Office
  • Avenue Ibirapuera, 2332
  • Tower1 - 13th floor IndianĂ³polis
  • Sao Paulo, 04028
  • Brazil

+55 (11) 0000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Moksha8’s full profile, request a free trial.

Moksha8 Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Later Stage VC 06-Jan-2014 $125M Cancelled Generating Revenue
8. Secondary Transaction - Private 22-Oct-2012 0000 00000 Completed Generating Revenue
7. Later Stage VC (Series 3) 14-Oct-2010 0000 00000 00000 Completed Startup
6. Convertible Debt 10-Jun-2010 00.00 000.00 Completed Startup
5. Later Stage VC (Series 2) 01-Dec-2009 000.00 000.00 000.00 Completed Startup
4. Convertible Debt 05-Nov-2009 000 000.00 Completed Startup
3. Convertible Debt 11-Feb-2009 00.000 000.00 Completed Startup
2. Early Stage VC (Series B) 30-Jan-2008 $15M $39M Completed Startup
1. Early Stage VC (Series A) 30-Jan-2008 $24M $24M Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Moksha8 Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series 3a 00,000,000 00.000000 0.00 00.0 00.0 00 00.0 00.000
Series 3a 00,000,000 00.000000 0.00 00.00 00.00 00 00.00 0.000
Series 2 00,000,000 00.000000 0.00 00.00 00.00 00 00.00 00.000
Series 1a 1,858,968 $0.001000 9.5% $3.29 $3.29 1x $3.29 1.25%
Series 1 18,706,466 $0.001000 9.5% $0.9 $0.9 1x $0.9 12.59%
To view this company’s complete Cap Table, request access »

Moksha8 Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Votorantim New Business Corporate Venture Capital Minority 000 0000 000000 0
Montreux Equity Partners Venture Capital Minority 000 0000 000000 0
GVK BIO VC-Backed Company Minority 000 0000 000000 0
Lit Tele Corporation Minority 000 0000 000000 0
TPG Biotech Venture Capital Minority 000 0000 000000 0

Moksha8 Executive Team (16)

Name Title Board
Seat
Contact
Info
Joel Barlan Chief Executive Officer & Board Member
Rogelio Sandoval Chief Financial Officer
Jamie Dick-Cleland Co-Founder
Akram Bouchenaki Ph.D Senior Vice President Global Strategic Marketing
Philip Ball Senior Vice President, Operations

9 Former Executives

You’re viewing 5 of 16 executives. Get the full list »

Moksha8 Board Members (12)

Name Representing Role Since Contact
Info
Arthur Higgins Self Board Member 000 0000
Daniel Turner III Montreux Equity Partners Board Member 000 0000
David Solomon JD Forest Laboratories Board Member 000 0000
Joel Barlan Moksha8 Chief Executive Officer & Board Member 000 0000
Pascal Forget Moksha8 Board Member 000 0000

6 Former Board Members

You’re viewing 5 of 12 board members. Get the full list »